ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
121.594,38
-0,36%
S&P 500
5.284,18
0,01%
US Dollar vs BRL
5,2902
0,76%
Bitcoin
70.628,15
2,65%
Brent Oil
77,505
-0,81%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Incyte Corporation (INCY)

  7. Incyte Corporation (INCY) Notícias

INCY Incyte Corporation

58,89
0,09 (0,15%)
Última atualização: 16:10:00
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Incyte Corporation INCY NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,09 0,15% 58,89 16:10:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
58,67 58,52 59,32 58,80
mais cotações »

Notícias Recentes

Data Hora Fonte Título
30/05/202417:05BWIncyte Completes Acquisition of Escient Pharmaceuticals
21/05/202414:15BWIncyte Expands Presence in Delaware through Acquisition of..
21/05/202409:00BWIncyte to Present at Upcoming Investor Conference
15/05/202422:45BWIncyte präsentiert Daten aus seinem Onkologie-Portfolio beim..
15/05/202412:44BWIncyte présentera les données de son portefeuille..
14/05/202418:00BWIncyte to Highlight Data From its Oncology Portfolio at the..
14/05/202410:05IHMARKETNEWSProducer Price Inflation Data May Weigh On Wall Street
13/05/202417:34IHMARKETNEWSDow Snaps Eight-Day Winning Streak After Lackluster Session
13/05/202408:00BWIncyte Announces Intention to Buy Back up to $2.0 Billion of..
02/05/202409:00BWIncyte to Present at Upcoming Investor Conference
30/04/202408:00BWIncyte Reports 2024 First Quarter Financial Results and..
23/04/202419:11BWIncyte annonce l'acquisition d'Escient Pharmaceuticals et de..
23/04/202419:01BWIncyte gibt Übernahme von Escient Pharmaceuticals und dessen..
23/04/202408:00BWIncyte Announces Acquisition of Escient Pharmaceuticals and..
11/04/202409:00BWIncyte to Report First Quarter Financial Results
01/04/202409:30BWIncyte and CMS Announce Collaboration and License Agreement..
29/03/202417:30BWIncyte Reports Inducement Grant Under Nasdaq Listing Rule..
11/03/202409:57BWIncyte annonce de nouvelles données de l’étude de phase 2..
11/03/202407:06BWIncyte présente de nouvelles données de l’étude de phase 2..
11/03/202406:53BWIncyte legt neue brandaktuelle Daten aus Phase-2-Studie zur..
10/03/202417:05BWIncyte Presents New Late-Breaking Data from Phase 2 Study..
04/03/202416:38BWDe nouvelles données dérivées du portefeuille dermatologique..
04/03/202416:02BWNeue Daten aus dem wachsenden Dermatologieportfolio von..
04/03/202410:00BWNew Data from Incyte’s Growing Dermatology Portfolio to be..
29/02/202412:19BWIncyte Launches The Unseen Journey to Elevate the Hidden..
29/02/202409:30GLOBEKnight Therapeutics Announces Launch of Minjuvi® in Brazil
28/02/202411:11BWIncyte annonce que la Food and Drug Administration des..
28/02/202409:15BWIncyte gibt bekannt, dass die US-Arzneimittelbehörde FDA..
27/02/202418:08BWIncyte Announces U.S. Food and Drug Administration Grants..
15/02/202410:00BWIncyte to Present at Upcoming Investor Conference
13/02/202409:00BWIncyte Reports 2023 Fourth Quarter and Year-End Financial..
06/02/202406:08BWIncyte erhält exklusive weltweite Rechte für die Entwicklung..
05/02/202422:55BWIncyte obtient les droits exclusifs de développement et de..
05/02/202418:46BWIncyte Gains Exclusive Global Development and..
23/01/202410:00BWIncyte to Report Fourth Quarter and Year-End 2023 Financial..
08/01/202410:30BWIncyte Highlights Growth Opportunities and Provides Business..
12/12/202310:00BWIncyte to Present at Upcoming Investor Conferences
11/12/202308:33BWIncyte und Syndax präsentieren bei ASH-Plenarsitzung weitere..
10/12/202319:00BWIncyte and Syndax Present Additional Data from Positive..
02/11/202310:00BWIncyte to Spotlight More Than 40 Hematology and Oncology..
31/10/202308:00BWIncyte Reports 2023 Third Quarter Financial Results and..
27/10/202309:00BWScience Magazine Recognizes Incyte as #2 “Top Employer” of..
19/10/202307:06IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
18/10/202309:00BWIncyte to Present at Upcoming Investor Conferences
16/10/202317:12BWIncyte kündigt neue Daten aus dem gesamten..
16/10/202309:00BWIncyte Announces New Data from across its Oncology Portfolio..
14/10/202313:30BWIncyte annonce de nouvelles données pour le ruxolitinib en..
13/10/202319:19BWIncyte gibt neue Daten für Ruxolitinib-Creme (Opzelura®®) in..
13/10/202311:30BWIncyte Announces New Data for Ruxolitinib Cream (Opzelura®)..
13/10/202309:00BWData From Incyte’s Povorcitinib Clinical Program to Be..

Seu Histórico Recente

NASDAQ
INCY
Incyte
BIT
UC5T0M
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados